Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen Therapy and Wound Microbiome in Chronic Wound Healing
2025-523863-39-00Phase 4Authorised
- Sponsor
- Medical University of Graz
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxygen in Chronic wound, diabetic foot ulcer (DFU), vascular ulcer and 3 more, sponsored by Medical University of Graz. Primary endpoints: Between-group difference in wound microbiome alpha-diversity at Week 6 and Longitudinal microbial diversity and composition. Planned start Feb 2026; status: authorised.
02
Drugs
oxygen
03
Conditions
Chronic wounddiabetic foot ulcer (DFU)vascular ulcerdecubitus ulcerbacterial disease
Beyond the preview
Go deeper on 2025-523863-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523863-39-00.